| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C16H23NO2 |
| Molar mass | 261.365 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Propylphenidate (also known as PPH) is a piperidine based stimulant drug, closely related to methylphenidate, but with the methyl ester replaced by a propyl ester. It was banned in the UK as a Temporary Class Drug from April 2015 following its unapproved sale as a designer drug.
Propylphenidate binds to the norepinephrine transporter in human embryonic kidney cells with an affinity similar to that of isopropylphenidate and ethylphenidate. However, its binding affinity for the dopamine transporter is 4 times lower, making it one of the methylphenidate analogues with the weakest affinity for DAT. On drug user forums, its subjective effects are described as very mild.
Propylphenidate is illegal in Sweden as of 26 January 2016, and in Finland since 2017.